Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marco Bonaso"'
Autor:
Nicoletta Luxi, Chiara Bellitto, Francesco Ciccimarra, Emiliano Cappello, Luca L’Abbate, Marco Bonaso, Chiara Ajolfi, Paolo Baldo, Roberto Bonaiuti, Claudio Costantino, Giovambattista De Sarro, Cristina Di Mauro, Giuseppina Fava, Marina Ferri, Alberto Firenze, Fabiana Furci, Luca Gallelli, Luca Leonardi, Giovanna Negri, Fabio Pieraccini, Elisabetta Poluzzi, Chiara Sacripanti, Elisa Sangiorgi, Ester Sapigni, Ilenia Senesi, Roberto Tessari, Luigia Trabace, Alfredo Vannacci, Francesca Venturini, Francesco Vitale, Donatella Zodda, Marco Tuccori, Gianluca Trifirò
Publikováno v:
Frontiers in Drug Safety and Regulation, Vol 4 (2024)
Introduction: In 2021, the European Medicines Agency supported the “Covid Vaccine Monitor (CVM),” an active surveillance project spanning 13 European countries aimed at monitoring the safety of COVID-19 vaccines in general and special populations
Externí odkaz:
https://doaj.org/article/ee027459a7634255bc452197c74de33d
Autor:
Irma Convertino, Massimiliano Cazzato, Silvia Tillati, Sabrina Giometto, Rosa Gini, Giulia Valdiserra, Emiliano Cappello, Sara Ferraro, Marco Bonaso, Claudia Bartolini, Olga Paoletti, Valentina Lorenzoni, Leopoldo Trieste, Matteo Filippi, Giuseppe Turchetti, Michele Cristofano, Corrado Blandizzi, Marta Mosca, Ersilia Lucenteforte, Marco Tuccori
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: The disease activity associated with the drug-utilization patterns of biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) is poorly investigated in real-world studies on rheumatoid arthritis (RA) patients. To investigate the relati
Externí odkaz:
https://doaj.org/article/0dd20fd9428f4f9aaf484373d027b0bb
Autor:
Irma Convertino, Valentina Lorenzoni, Rosa Gini, Giuseppe Turchetti, Elisabetta Fini, Sabrina Giometto, Claudia Bartolini, Olga Paoletti, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Corrado Blandizzi, Marco Tuccori, Ersilia Lucenteforte
Publikováno v:
Pharmaceuticals, Vol 16, Iss 3, p 465 (2023)
This study is aimed at describing tofacitinib and baricitinib users by characterizing their prescription and healthcare histories, drug and healthcare utilization patterns, and direct costs from a healthcare system perspective. This retrospective coh
Externí odkaz:
https://doaj.org/article/a99c4db821484d31be05aec53e4084f9
Autor:
Irma Convertino, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Marco Tuccori
Publikováno v:
Expert Opinion on Drug Discovery. 18:231-245
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0ac1e55ef8de5256f36a68ba9ddfbd7
https://doi.org/10.1080/17460441.2023.2170348
https://doi.org/10.1080/17460441.2023.2170348